お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
985001

シングルセル (単一細胞) ゲノミクス市場

Single Cell Genomics Markets

出版日: | 発行: Kalorama Information | ページ情報: 英文 43 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.58円
シングルセル (単一細胞) ゲノミクス市場
出版日: 2020年12月23日
発行: Kalorama Information
ページ情報: 英文 43 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

個別細胞からDNAまたはRNAを増幅する能力は重要な開発でした。過去15年間の継続的な技術進歩の結果として、NGSの使用が、生物学的研究の幅広い分野で受け入れられてきました。同時に、多数の個別細胞を並行して分離および調製できるようにするために、さまざまな新製品が導入されました。

当レポートでは、シングルセル (単一細胞) ゲノミクス市場について調査分析し、最新の市場情勢について、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場分析

  • 市場分析
  • 収益予測
  • 競合分析
  • 製品
  • 新製品

企業プロファイル:

  • 10X Genomics
  • Bio-Rad
  • Dolomite Bio
  • Fluidigm
  • Illumina
  • Mission Bio
  • Qiagen
  • Takara Bio
目次
Product Code: 20-035

The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA or RNA from an individual cell was a key development. As a result of continuous technological advances in the last 15 years, the use of NGS has constantly gained more acceptance in broad areas of biological research. At the same time, a range of new products have been introduced to allow the isolation and preparation of large numbers of individual cells in parallel. Along with other technological innovations, these have resulted in new capabilities to routinely study large numbers of genes in tens or hundreds of thousands of individual cells.

This report, ‘Single Cell Genomics Markets ’, provides the most current market research into single cell genomics and the companies that participate in this market. As part of its coverage, the report contains the following information:

  • Single Cell Genomics Products on the Market
  • Market for Single Cell Genomics, 2019-2025
  • Consumables Market, 2019-2025
  • Instrument Market, 2019-2025
  • Litigation and IP
  • Profiles of Companies in the Market
  • Participation Matrix (Who Participates in Single Cell Genomics and Other Genomics Areas)
  • Recent Product Introductions

Companies Profiled include:

  • 10X Genomics
  • Bio-Rad
  • Dolomite BIo
  • Fluidigm
  • Illumina
  • Mission Bio
  • Qiagen
  • Takara BIo

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • OVERVIEW
    • Table 1-1: Market for Single Cell Genomics
    • Figure 1-1: Market by Type
  • PRODUCTS ON THE MARKET
    • Table 1-2: Companies in the Market
  • SCOPE AND METHODOLOGY

CHAPTER TWO: INTRODUCTION

  • INTRODUCTION
  • APPLICATIONS
    • Infectious Disease
    • Understanding Cancer with miRNAs
    • Atherosclerosis Research
    • Neurological
  • MARKET TRENDS
    • Increasing Numbers of Cells Analyzed
    • Significant Interest in Multi-omics
    • Spatial Transcriptomics, In Situ Techniques Gaining Traction
    • Data Analysis, Data Volumes, High Dimensionality Challenging
    • Convergence of Technological Advances
    • Litigation With Most Major Companies
      • Table 2-1: Litigation in the Single Cell Genomics Market

CHAPTER THREE: MARKET ANALYSIS

  • MARKET ANALYSIS
  • REVENUES FORECAST
    • Figure 3-1: Breakdown of Market by Type (Consumables Instruments) 2019-2025
    • Table 3-1: Market for Single Cell Genomics, 2019-2025 (Consumables and Instruments), $M
    • Figure 3-2: Market Growth Over Time, $M
    • Table 3-2: Market for Single Cell Genomics by Region, $m and %
  • COMPETITIVE ANALYSIS
    • Figure 3-3: Participation Matrix of Major Competitors (Single Cell Sequencing, Other Sequencing Areas, Major/Minor and Moderate Participation)
  • PRODUCTS
    • Table 3-3: Products on the Market
  • New Products
    • Table 3-4: Product Introductions

COMPANY PROFILES:

  • 10X Genomics
  • Bio-Rad
  • Dolomite Bio
  • Fluidigm
  • Illumina
  • Mission Bio
  • Qiagen
  • Takara Bio
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.